Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT
Altamira Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | -2.7 | -4.59 | -28.69 | -18.71 | -9.27 | -6.85 | Upgrade
|
| Depreciation & Amortization | 0.13 | 0.14 | 0.13 | 0.08 | 0.02 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 13.41 | 1.68 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.28 | 0.05 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.48 | 0.45 | 0.37 | 1.32 | 0.42 | 0.23 | Upgrade
|
| Other Operating Activities | 0.78 | 1.62 | 1.62 | 1.03 | 3.01 | -0.82 | Upgrade
|
| Change in Accounts Receivable | 0.05 | 0.02 | -0.11 | -0.37 | 0.29 | -0.02 | Upgrade
|
| Change in Inventory | -0.07 | -0.38 | 0.89 | -0.92 | - | - | Upgrade
|
| Change in Accounts Payable | -0.45 | -3.92 | 1.37 | 3.22 | -0.2 | -0.93 | Upgrade
|
| Change in Other Net Operating Assets | -0.17 | -0.75 | 1.7 | -1.73 | 0.25 | -0.32 | Upgrade
|
| Operating Cash Flow | -7.58 | -13.67 | -9.39 | -15 | -5.47 | -8.67 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.07 | Upgrade
|
| Divestitures | 2.14 | 2.29 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.32 | -3.65 | -2.62 | -3.05 | Upgrade
|
| Investment in Securities | -0.53 | -0.57 | - | -0.2 | - | - | Upgrade
|
| Other Investing Activities | 0 | 0 | 0 | - | 0 | 0.02 | Upgrade
|
| Investing Cash Flow | 1.61 | 1.72 | -2.32 | -3.84 | -2.62 | -3.1 | Upgrade
|
| Short-Term Debt Issued | - | 2.97 | 6.53 | - | 1.72 | - | Upgrade
|
| Total Debt Issued | 0.04 | 2.97 | 6.53 | - | 1.72 | - | Upgrade
|
| Short-Term Debt Repaid | - | -1.59 | - | -0.05 | - | -1.51 | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.12 | -0.02 | - | - | Upgrade
|
| Total Debt Repaid | -1.52 | -1.72 | -0.12 | -0.08 | - | -1.51 | Upgrade
|
| Net Debt Issued (Repaid) | -1.47 | 1.25 | 6.41 | -0.08 | 1.72 | -1.51 | Upgrade
|
| Issuance of Common Stock | 8.31 | 12.48 | 4.29 | 7.51 | 18.17 | 10.11 | Upgrade
|
| Other Financing Activities | -0.91 | -1.11 | -0.06 | -0.18 | -0.72 | -0.98 | Upgrade
|
| Financing Cash Flow | 5.92 | 12.61 | 10.63 | 7.25 | 19.17 | 7.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.06 | 0.03 | 0.32 | 0.08 | 0.01 | Upgrade
|
| Net Cash Flow | -0.04 | 0.71 | -1.05 | -11.27 | 11.16 | -4.14 | Upgrade
|
| Free Cash Flow | -7.58 | -13.67 | -9.39 | -15 | -5.47 | -8.73 | Upgrade
|
| Free Cash Flow Per Share | -5.35 | -27.83 | -206.22 | -452.91 | -364.11 | - | Upgrade
|
| Cash Interest Paid | 0.15 | 0.18 | 0.02 | 0 | - | 0 | Upgrade
|
| Levered Free Cash Flow | -5.42 | -10.9 | -2.81 | -7.79 | -5.03 | -8.76 | Upgrade
|
| Unlevered Free Cash Flow | -5.06 | -10.13 | -2.2 | -7.78 | -4.94 | -8.74 | Upgrade
|
| Change in Net Working Capital | 0.96 | 5.88 | -3.78 | 0.56 | -0.97 | 1.2 | Upgrade
|
Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.